Clinical Trial Update: Observational Study to Assess Sociodemographic and Clinical Features of Patients Treated With Rivaroxaban in Routine Clinical Practice of Hematologists, Cardiologists and Internists of Spain

View source ↗

Summary

This is an observational study evaluating sociodemographic and clinical features of patients with atrial fibrillation treated with rivaroxaban in routine clinic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED